Next Article in Journal
Pediatric and Adult High-Grade Glioma Stem Cell Culture Models Are Permissive to Lytic Infection with Parvovirus H-1
Next Article in Special Issue
Aerosol Transmission of Filoviruses
Previous Article in Journal
The Effect of MicroRNA bantam on Baculovirus AcMNPV Infection in Vitro and in Vivo
Previous Article in Special Issue
Validation of the Filovirus Plaque Assay for Use in Preclinical Studies
Article Menu

Export Article

Viruses 2016, 8(5), 137; https://doi.org/10.3390/v8050137

Correction
Correction: Reynard, O.; et al. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233‒6240
MDPI AG, Klybeckstrasse 64, CH-4057 Basel, Switzerland
Received: 9 May 2016 / Accepted: 9 May 2016 / Published: 18 May 2016
The Viruses Editorial Office wishes to notify its readers of corrections in [1].
The authors refer to [2], writing that the experiments were done using 126 mM/kg/day for mouse treatment without side effects. The correct dose used in [2] was 126 µmol/kg/day.
On page 6235, the last sentence of the first paragraph should read: “These data are in line with published reports on the absence of significant toxicity caused by the inhibitor at the concentration below 75–100 M in Madin-Darby canine kidney cells (MDCK), human hepato cellular carcinoma cells (HUH), HepG2 cells or ex vivo in human peripheral blood monocytes [13], as well as in a mouse model where NHC was provided up to 126 µmol per kilogram of body weight during five consecutive days without any measurable side effects [13]”.
The original Figure 3 was in French and has been replaced by the following:
Viruses 08 00137 g001
The manuscript will be updated and the original will remain available on the article webpage. The authors would like to apologize for any inconvenience caused.

References

  1. Reynard, O.; Nguyen, X.-N.; Alazard-Dany, N.; Barateau, V.; Cimarelli, A.; Volchkov, V.E. Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication. Viruses 2015, 7, 6233–6240. [Google Scholar] [CrossRef] [PubMed]
  2. Stuyver, L.J.; Whitaker, T.; McBrayer, T.R.; Hernandez-Santiago, B.I.; Lostia, S.; Tharnish, P.M.; Ramesh, M.; Chu, C.K.; Jordan, R.; Shi, J.; et al. Ribonucleoside analogue that blocks replication of bovine viral diarrhea and hepatitis C viruses in culture. Antimicrob. Agents Chemother. 2003, 47, 244–254. [Google Scholar] [CrossRef] [PubMed]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top